Views: 0 Author: Sayt Ɛditɔ Pɔblish Taym: 2025-12-02 Ɔrijin: Ples
pan ɔl we puls ɔksimɛtri dɔn tradishɔnal wan gɛt fɔ du wit klinik ɛnvayrɔmɛnt ɔ spɛshal pasɛnt grup dɛn, dɛn de no am mɔ ɛn mɔ as valyu kɔmpɔnɛnt fɔ ɛvride wɛlbɔdi mɛnejɛmɛnt. fכ pipul dεm we gεt hεlth, fכ כndastand di bכdi כksijεn satεrayshכn (SpO2) de gi imכtant insayt fכ di fysiolojikal pεrformεns εn i kin εp fכ no di fכs sayn dεm fכ di hεlth ishu dεm we kin bi.
di bכdi כksijεn sεtyureshכn de sho aw כksijεn de transpכt fayn fayn wan tru di bכdi—na imכtant tin we de infכlכw di כl di fכshal fכnshכn. ivin bitwin di wan dεm we de yuz hεlty, di SpO2 lεvεl kin chenj כnda difrεn kכndishכn dεm. Fɔ wach ɔltɛm de gi mininful wɛlbɔdi gayd akɔdin to difrɛn sɛnɛriɔ dɛm:
εksεsayz Pεrformεns Optimayzεsh
כn Trak SpO2 εn post-εksεsayz rεkכvεshכn de sכpכt evalueshכn fכ di kכdiכpulmonari adapteshכn εn i de εp כptimayz di trenin intensiti.
Ay-Altitud Travul Protɛkshɔn
Fɔ monitar ɔksijɛn satyureshɔn we yu de travul na ay-altitud ɔ we yu de du tin dɛn na mawnten, dat de alaw fɔ no kwik kwik wan fɔ di lɔw ɔksijɛn kɔndishɔn ɛn i de ɛp fɔ mek yu gɛt ɛkspiriɛns we sef.
Slip Kwaliti Asɛsmɛnt
Fɔ no di nɛt ɔksijɛn dɛsaturashɔn tren de gi data we kin sɔpɔt impɔtant slip kwaliti.
Fatigue ɛn Overexertion Detection
Abnɔmal SpO2 fluktueshɔn kin sho fɔs sayn dɛm fɔ fyzikal strɛs, ɛp wan wan pipul dɛm fɔ ajɔst di wok intensiti ɛn rikavari plan dɛm.
Joytech in puls ɔksimita siriɔs dɛn de divɛlɔp ɔnda wan kɔmprɛhɛnsif intanashɔnal kwaliti sistɛm, we de mek shɔ se kɔnsistɛns ɛn dipendabl mɛzhɔmɛnt pefɔmɛns. Ki sɛtifikeshɔn maylston dɛn inklud:
2021: FDA kliarens
2022: Chaina in fɔs puls ɔksimita rɛjista sɛtifiket
2024: MDR CE sɛtifiket, wit di ful prodak siriɔs ɔpgrɛd fɔ fala di laytst standad dɛn
Dɛn tin ya we dɛn dɔn du de sho se dɛn dɔn mekɔp dɛn maynd fɔ fala di lɔ, sef, ɛn fɔ rilaybiliti fɔ lɔng tɛm fɔ difrɛn nid dɛn na di makit.
We dɛn put di blɔd ɔksijɛn trak insay di tin dɛn we dɛn kin du ɛvride, dat kin mek wan wan pipul dɛn ebul fɔ:
Establish pasכnal SpO2 beslayn rεnj dεm εn aydentify divεlכpmεnt dεm
Mek layf stayl ajɔstmɛnt dɛn we dɛn sɔpɔt bay kwantiti data
Tek tin fɔ mek yu nɔ gɛt dis sik bifo yu notis di sayn dɛm
Gɛt mɔ kɔmplit ɔndastandin bɔt ɔl di bɔdi wɛl bɔdi
Wit dipendabl monitarin teknɔlɔji, prɛvɛntiv wɛlbɔdi mɛnejɛmɛnt kin bi mɔ aksesbul ɛn data-driven.
Sɛtifiket dɛn lɛk FDA kliarens, Chaina in rɛjista aprɔval ɛn CE MDR kɔmplians de sho se di prɔdak siriɔs mit strikt rigyuletɔri rikwaymɛnt dɛn akɔdin to bɔku men makit dɛn. Fɔ di wan dɛn we de bay, dis de ɛp fɔ mek i izi fɔ mek dɛn go insay di makit, i de ridyus di prɔblɛm dɛn we dɛn kin gɛt fɔ gri fɔ mek dɛn gɛt di prɔblɛm ɛn mek shɔ se di divays de wok ɔltɛm.
Yɛs. Di data we dɛn pul frɔm SpO2 monitarin—lɛk ɛksɛsayz rikavari, ɔksijɛn chenj we gɛt fɔ du wit ayt, ɛn dɛsaturashɔn we gɛt fɔ du wit slip—kin sɔpɔt wɛlbɔdi pletfɔm, os wɛlbɔdi program, ɛn brand dɛn we de gi data-driven wɛlbɔdi divays.
Wi tim de gi spɛsifikɛshɔn shit, sɛtifikeshɔn dɔkyumentri, ɛn tɛnki sɔpɔt fɔ ɛp patna dɛn fɔ asɛs di mɔdel suitability bays pan di makit rikwaymɛnt ɛn pefɔmɛns nid.
Rikwest prodak spesifikeshɔn ɔ kɔmplians dɔkyumɛnt fɔ ɛksplɔrɔ fayn puls ɔksimita mɔdel fɔ yu makɛt nid.